Wednesday - November 04, 2026

Rare NRG1 Fusion Market Size in the 7MM is projected to increase over the forecast period of 2024-2034 | DelveInsight

The Key Rare NRG1 Fusion Companies in the market include – Elevation Oncology, Merus, Hummingbird Bioscience, Boehringer Ingelheim, AVEO Oncology, CANbridge Pharmaceuticals, Salubris Biotherapeutics, and others. (Albany, US), November 04, 2026 – DelveInsight’s ‘Rare NRG1 Fusion Market Insights, Epidemiology, and … Continue reading →